The role of dopamine receptors in regulating the formation of recognition memory remains poorly understood. Here we show the effects of systemic administration of dopamine receptor agonists and antagonists on the formation of memory for novel object recognition in rats. In Experiment I, rats received an intraperitoneal (i.p.) injection of vehicle, the selective D1 receptor agonist SKF38393 (1.0 and 5.0 mg/kg), or the D2 receptor agonist quinpirole (1.0 and 5.0 mg/kg) immediately after training. In Experiment II, rats received an injection of vehicle, the dopamine receptor antagonist SCH23390 (0.1 and 0.05 mg/kg), or the D2 receptor antagonist raclopride (0.5 and 0.1 mg/kg) before training, followed by an injection of vehicle or the nonselective dopamine receptor agonist apomorphine (0.05 mg/kg) immediately after training. SKF38393 at 5 mg/kg produced an enhancement of novel object recognition memory measured at both 24 and 72 h after training, whereas the dose of 10 mg/kg impaired 24-h retention. Posttraining administration of quinpirole did not affect 24-h retention. Apomorphine enhanced memory in rats given pretraining raclopride, suggesting that the effect was mediated by selective activation of D1 receptors. The results indicate that activation of D1 receptors can enhance recognition memory consolidation. Importantly, pharmacological activation of D1 receptors enhanced novel object recognition memory even under conditions in which control rats showed significant retention.
Introduction
Dopamine is a key neurotransmitter regulating cognitive processes. Many aspects of brain function that influence memory, such as reward, attention and fear have been shown to be regulated by dopaminergic transmission (Cropley, Fujita, Innis, & Nathan, 2006; Egerton et al., 2009; Seamans & Yang, 2004) . There are two main classes of dopamine receptors that are categorized by their ability to stimulate (D1-like) or inhibit (D2-like) the adenylyl cyclase/cAMP/ protein kinase A (PKA) pathway (El-Ghundi, O'Dowd, & George, 2007; Jaber, Robinson, Missale, & Caron, 1996; Mehta & Riedel, 2006) . More recently, it has become evident that the different classes of dopamine receptors could exert distinct effects on recognition memory (Braszko, 2006 (Braszko, , 2009 Braszko, Wielgat, & Walesiuk, 2008; Hotte, Naudon, & Jay, 2005; Maroun & Akirav, 2009; Nagai et al., 2007 Nagai et al., , 2009 ). This type of memory can be tested in rodents using the novel object recognition task, which is based on spontaneous activity and the natural preference that rodents display to explore a novel object more than a familiar one when the animal remembers previous exposure to the familiar object. Advantages associated with this class of measure include the fact that performance does not require salient positive or negative reinforcers, such as food deprivation or application of an electric shock (Clark & Martin, 2005; Dix & Aggleton, 1999; Ennanceur & Delacour, 1988; Mumby, 2001) .
Recognition memory has been shown to be influenced by the nigrostriatal dopaminergic pathway (Belcher, Feinstein, O'Dell, & Marshall, 2008; Belcher, O'Dell, & Marshall, 2005 , 2006 Besheer, Jensen, & Bevins, 1999; Moses, Cole, Driscoll, & Ryan, 2005; Mumby, 2001; Mumby, Gaskin, Glenn, Schramek, & Lehmann, 2002; Schrö-der, O'Dell, & Marshall, 2003; Wais, Wixted, Hopkins, & Squire, 2006) . However, the specific receptor subtypes mediating the behavioral effects of dopamine in the different phases (acquisition, consolidation and retrieval) of recognition memory remain poorly understood. The purpose of the present study was to evaluate the 1074-7427 doi:10.1016/j.nlm.2010.12.007 effects of pharmacological manipulation of dopamine D1 and D2 receptors on recognition memory consolidation. In order to do that, we performed two experiments: in Experiment I, rats received vehicle, the selective D1 receptor agonist SKF38393, or the D2 receptor agonist quinpirole immediately after the training trial in a novel object recognition task. In Experiment II, rats received vehicle, SCH23390 (a selective dopamine D1 receptor antagonist) or raclopride (a selective dopamine D2 receptor antagonist) 15 min before training, followed by a posttraining injection of vehicle or the nonspecific dopamine receptor agonist apomorphine.
Materials and methods

Animals
Male Wistar rats were obtained from the State Health Research Foundation (FEPPS, Porto Alegre, Brazil). The rats were maintained in groups of five animals in a plastic cage with sawdust bedding in a room temperature of 22 ± 1°C and a 12:00/12:00 h light/dark cycle. The animals were supplied with standardized pellet food and tap water ad libitum. Behavioral testing started when animals reached the age of 3 months. All behavioral experiments took place between 9:00 and 17:00 h. The experimental procedures were performed in accordance with the NIH Guide for Care and Use of Laboratory Animals (NIH publication number 80-23 revised 1996) and approved by the institutional Animal Care Committee (Pontifical Catholic University, 471/05-CEP). All efforts were made to minimize the number of animals and their suffering.
Treatments
In Experiment I, vehicle (5% dimethyl sulfoxide (DMSO) in saline), SKF38393 (1.0 and 5.0 mg/kg of body weight), or quinpirole (1.0 and 5.0 mg/kg of body weight) was administered intraperitoneally (i.p.) immediately after object recognition training. In Experiment II, vehicle, SCH23390 (0.05 and 0.1 mg/kg), or raclopride (0.5 and 0.1 mg/kg) was administered i.p. 15 min before training, and the same animals received a second i.p. injection of vehicle or apomorphine (0.05 mg/kg) immediately after training. Drug doses were based on previous studies (Besheer et al., 1999; Huang & Kandel, 1995; Mehta, Montgomery, Kitamura, & Grasby, 2008; Passetti, Levita, & Robbins, 2003; Picada, Schröder, Izquierdo, Henriques, & Roesler, 2002; Ponnusamy, Nissim, & Barad, 2005) . All drugs were dissolved in 5% DMSO and were purchased from Sigma-Aldrich (Saint Louis, MO, USA).
Novel object recognition
The novel object recognition task was performed as previously described (de Lima, Laranja, Bromberg, Roesler, & Schroder, 2005; de Lima et al., 2008) . Briefly, the novel object recognition task took place in an open field apparatus (45 Â 40 Â 60 cm) with sawdust covering its floor. On the first day, rats underwent a habituation session during which they were placed in the empty open field for 5 min. On the following day, rats were given one 5-min training trial in which they were exposed to two identical objects (A1 and A2). The objects were positioned in two adjacent corners, 9 cm from the walls. On the first long-term memory (LTM) testing trial (24 h after the training session), rats were allowed to explore the open field for 5 min in the presence of two objects: the familiar object A and a novel object B. A subset of rats also underwent a second LTM retention test trial at 72 h after the training session, in which rats were allowed to explore the open field for 5 min in the presence of the familiar object A and a third novel object C. These were placed in the same locations as in the training session. All objects presented similar textures, colors, and sizes, but distinctive shapes. Between trials the objects were washed with 10% ethanol solution. Object exploration was measured using two stopwatches to record the time spent exploring the objects during the experimental sessions. Exploration was defined as follows: sniffing or touching the object with the nose. Sitting on the object was not considered as exploration. Animals that did not explore the objects during the training or retention testing sessions were excluded from the study. A recognition index calculated for each animal was expressed by the ratio T N /(T F + T N ) [T F = time spent exploring the familiar object (or object A2 in training trials); T N = time spent exploring the novel object (or object A1 in training trials].
Statistics
Comparisons in exploratory preferences among groups were performed with a Kruskal-Wallis analysis of variance followed by Mann-Whitney U tests when necessary. Comparisons in total time exploring objects was analyzed with a one-way analysis of variance (ANOVA) followed by Tukey post hoc tests when appropriate. Data are shown as mean ±SEM; p values of less than 0.05 were considered to indicate statistical significance.
Results
Experiment I
There was no significant difference among groups in the total time spent exploring both objects during training [F(5, 46) = 1.68, p = 0.16; overall mean ± SEM time exploring both objects (s) was 37.02 ± 1.70)]. For clarity reasons, Fig. 1 shows the results for posttraining administration of the D1 receptor agonist, whereas the results for posttraining administration of the D2 receptor agonist are shown in Fig. 2 . Kruskal-Wallis test showed a significant difference among groups in exploratory preferences in the long-term recognition memory retention trial performed 24 h after the training (df = 5, H = 4.345, p < 0.001), but not in the training trial (df = 5, H = 29.551, p = 0.501). Further analyses with Mann-Whitney U tests indicated that administration of the D1 receptor agonist, SKF38393 at the dose of 1.0 mg/kg of body weight (n = 7) did not alter the performance of the animals when compared to vehicle group (p = 0.837, n = 9). However, the administration of SKF38393 at the dose of 5.0 mg/kg (n = 9) induced a long-term recognition memory enhancement, since the recognition index of this group was significantly higher than the recognition index obtained in the vehicle group in the retention trial performed 24 h after training trial (p < 0.05). In contrast, the group that received SKF38393 at the dose of 10.0 mg/kg (n = 9) presented recognition memory impairment when compared with the vehicle group (p < 0.01, Fig. 1A) . The results indicate that the memory-influencing effect of the dopamine D1 receptor agonist follows an inverted U-shaped dose-response pattern, where lower and higher doses displayed opposite effects on memory formation. To verify whether the memory enhancement produced by SKF38393 persisted at a later interval, an additional retention test was carried out at 72 h after training in control rats and animals treated with 5 mg/kg SKF38393. Rats given SKF38393 showed enhanced memory retention compared to controls 72 h after training (p < 0.01, Fig. 1B) .
Results for exploratory preferences during retention testing in rats given the D2 receptor agonist are shown in Fig. 2 . Mann-Whitney comparisons between vehicle group (n = 9) and the groups that received quinpirole at either 1.0 mg/kg (n = 9) and 5.0 mg/kg (n = 9) showed no significant difference (both ps > 0.09) in a 24-h retention test.
Experiment II
Analysis with ANOVA revealed a significant difference in total times exploring objects during training [F(9, 84) = 7.18, p < 0.001).
However, further analysis with Tukey post hoc tests showed significant differences only in the comparisons between the group treated with raclopride at 0.1 mg/kg followed by apomorphine (n = 10) and the groups treated with SCH23390 followed by vehicle (ns = 10; both ps < 0.001). These differences were related to an apparent reduction in exploration in rats given pretraining SCH23390 (mean ± SEM time exploring objects (s) was 13.13 ± 2.96 at the dose of 0.05 mg/kg; p = 0.24 compared to controls and 8.43 ± 1.18; p = 0.06 compared to controls); in the control group given vehicle plus vehicle (n = 10), mean ± SEM time exploring objects (s) was 25.96 ± 5.01. No significant differences between control rats given vehicle before and after training and other groups were found. In addition, in spite of the apparent reduction in exploration, rats given pretraining SHC23390 showed normal exploratory preferences in training and test trials (see below). Overall mean ± SEM time exploring both objects (s) was 18.83 ± 1.45.
Results for exploratory preferences during retention testing are shown in Fig. 3A (dopamine D1/D2 receptor activation by apomorphine following dopamine D1 receptor blockade) and 3B (dopamine D1/D2 receptor activation by apomorphine following dopamine D2 receptor blockade). Kruskal-Wallis tests showed a significant difference among groups in exploratory preferences in the long-term recognition memory retention trial performed 24 h after training (df = 9, H = 23.08, p = 0.006), but not in the training trial (df = 9, H = 13.04, p = 0.161). Further analyses with MannWhitney U tests indicated that pretraining administration of SCH23390 (a specific dopamine D1 receptor antagonist) at the doses of 0.05 and 0.1 mg/kg did not influence the recognition memory acquisition and/or consolidation, since the recognition index of these groups were not statistically different from the vehicle + vehicle group (p = 0.739 and p = 853, for SCH23390 0.05 mg/ kg + vehicle and SCH23390 0.1 mg/kg + vehicle, respectively; ns = 10). Mann-Whitney U tests also indicated that pretraining administration of raclopride (a specific dopamine D2 receptor antagonist) at the doses of 0.1 and 0.5 mg/kg did not influence recognition memory acquisition and/or consolidation, since the recognition index of these groups were not significantly different from the vehicle + vehicle group (p = 0.579 and p = 0.278, for raclopride 0.1 mg/kg + vehicle, n = 10; and raclopride 0.5 mg/kg + vehicle, n = 9, respectively). Mann-Whitney U tests indicated that nonselective activation of D1 and D2 receptors did not affect recognition memory consolidation, since the recognition index of the group that received pretraining administration of vehicle combined with posttraining administration of apomorphine was not different from the vehicle + vehicle group, although it fell short of significance (p = 0.063; n = 10). Interestingly, Mann-Whitney U tests indicated that pretraining administration of raclopride at the dose of 0.5 mg/kg combined with posttraining administration of apomorphine (n = 8) induced memory enhancement, since the recognition index of this group was significantly higher than the recognition index obtained in the vehicle + vehicle group (p = 0.019, Fig. 3B ). The mean ± SEM total time (s) exploring objects during training was very similar in the control group given vehicle before and after training and the group treated with 0.5 mg/kg raclopride followed by apomorphine (25.96 ± 5.01 and 25.03 ± 5.81, respectively), indicating that the effect could not be attributed to alterations in locomotion, motivation, or sensorial function. The results suggest that apomorphine was able to produce an enhancement of memory consolidation in a condition in which D2 receptors were blocked by raclopride, possibly by selectively activating D1 receptors under those conditions.
Discussion
The present findings can be summarized as follows: in Experiments I and II, selective dopamine D1 and D2 receptor agonists were administered immediately after training in the novel object recognition task in order to investigate the role of these types of dopamine receptors in memory consolidation. Rats that received a selective dopamine D1 receptor agonist at an intermediate dose presented a long-term enhancement of recognition memory measured both at 24 and 72 h after training compared to vehicle group. In Experiment II, posttraining administration of the nonselective dopamine receptor agonist apomorphine was combined with pretraining injections of a D1 (SCH23390) or D2 (raclopride) antagonist. Apomorphine produced an enhancement of memory in the presence of the D2 receptor antagonist, an effect likely mediated by selective D1 receptor activation. Although the memory enhancement observed in 24-h tests was discrete, it was clearly statistically significant. It is also noteworthy that apomorphine, the D2 receptor agonist quinpirole, and the D1 receptor antagonist SCH23390 did not produce memory impairments when given alone. It is possible that, under the conditions used in the present study, recognition memory is modulated by the dopaminergic system in a way that memory consolidation can be enhanced by D1 receptor activation, but dopamine receptors are not critical for memory formation, thus neither D1 receptor blockade nor D2 receptor activation impair memory.
Previous reports have described an important role for dopamine receptors in synaptic plasticity and memory processing, and the effects of dopamine D1 and D2 receptor agonists and antagonists in Fig. 3 . Recognition memory in rats given a pretraining systemic injection of vehicle, the D1 receptor antagonist SCH23390 (SCH; A), or the D2 receptor antagonist raclopride (RAC; B), followed by a posttraining systemic injection of vehicle or the nonselective dopamine receptor agonist apomorphine. Retention test was carried out 24 h after training. The proportion of the total exploration time that the animal spent investigating the novel object was the ''Recognition Index'' expressed by the ratio T N /(T F + T N ) [T F = time spent exploring the familiar object; T N = time spent exploring the novel object]. Data expressed as median [interquartile ranges]; n = 8-10 per group. Differences between vehicle + vehicle vs. other groups are indicated as:
different rodent models of learning and memory have been extensively characterized (Chen et al., 1995; Huang & Kandel, 1995; Manago, Castellano, Oliverio, Mele, & De Leonibus, 2008; Passetti et al., 2003; Ponnusamy, Nissim, & Barad, 2005; Sajikumar & Frey, 2004; Umegaki et al., 2001; Wall, Blanchard, Yang, & Blanchard, 2003) . Although several studies have reported memory facilitation by either quinpirole and other D2 receptor agonists (e.g., Sigala, Missale, & Spano, 1997; White, Packard, & Seamans, 1993) , other studies have found that posttraining administration of quinpirole increased the latency of choices in delayed-non-matching-to-sample, a task related to recognition memory task, in rats (Chrobak & Napier, 1992) . In addition, systemic administration of quinpirole potentiated the memory-impairing effect of intra-cerebral infusion of a nicotinic cholinergic receptor antagonist on spatial working memory in rats (Kim & Levin, 1996) . These later results are consistent with our findings suggesting that, at least under some conditions, D1 and D2 receptors can play opposing roles in modulating memory consolidation.
Although dopamine D1 and D2 receptors have been clearly implicated in recognition memory processing, their role in the different phases (acquisition, consolidation and retrieval) of this type of memory remains poorly understood. Recognition memory may involve the participation of a large network of cortical connections that include the perirhinal cortex (Winters & Bussey, 2005a , 2005b , 2005c , the prefrontal cortex (Ventura, Pascucci, Catania, Musumeci, & Puglisi-Allegra, 2004; Xiang & Brown, 2004) and the hippocampus (de Lima, Luft, Roesler, & Schröder, 2006; Moses et al., 2005; Mumby et al., 2002; Wais et al., 2006) , where dopamine receptors appear to be required within a defined time window to store the information about objects. It has been recently shown that the consolidation of object recognition memory is accompanied by potentiation of CA3-CA1 hippocampal synapses (Clarke, Cammarota, Gruart, Izquierdo, & Delgado-García, 2010) , and D1 receptor knockout mice or mice given intrahippocampal infusion of a Drd1a-small interfering RNA show reduced plasticity in CA3-CA1 synapses, which were accompanied by memory deficits (Ortiz et al., 2010) . These findings indicate that D1 receptor-dependent synaptic plasticity in the dorsal hippocampus might be critically involved in the consolidation of object recognition memory. Further studies should examine the effects of D1 and D2 receptor agonists and antagonists on consolidation of object recognition memory when infused directly into the dorsal hippocampus. Besheer and colleagues (1999) showed that systemic injection of the dopamine D1 receptor antagonist SCH23390 before the retention test impairs the performance of rats in detecting a novel object. In addition, Hotte and colleagues (2005) showed that systemic injection of the dopamine D1 receptor agonist SKF81297 prior to the testing trial improves the performance of rats in the object recognition, object location and object temporal order tasks. The same group performed a second study investigating the signal transduction pathways underlying dopamine D1 receptor modulation of retrieval performance in these memory tasks at different delays. They found that the improvement in recognition and temporal order memory performance at a 4 h-delay was associated with an increased phosphorylation of both cAMP response element binding protein (CREB) and dopamine and cAMP-regulated phosphoprotein, 32 kDa (DARPP-32) in the prefrontal cortex of rats treated with the D1 agonist SKF81297. In contrast, the significant impairment of delayed spatial memory retrieval after administration of the selective D1 antagonist SCH23390 was associated with decreased phosphorylation of CREB and DARPP-32 in the prefrontal cortex (Hotte et al., 2006) . However, it is important to note that activation of D1 receptors can have exactly opposing functional effects depending on the level of stimulation. An inverted U-shaped function relating cognitive performance to D1 stimulation levels was reported (Goldman-Rakic, Muly, & Williams, 2000; Williams & Castner, 2006) . Interestingly, while dopamine D1 receptor stimulation usually improves cognition, the participation of dopamine D2 receptors in recognition memory tasks performed with healthy subjects was shown to be different than that observed in memoryimpaired subjects. Dopamine D2 receptor agonism generally exerts a positive effect in memory-impaired subjects and a negative effect in healthy subjects in both preclinical (Willig, Van de Velde, Laurent, M'Harzi, & Delacour, 1992; Léna et al., 2001; Prediger, Da Cunha, & Takahashi, 2005; Braszko, 2006) and clinical studies (Bédard, Scherer, Delorimier, Stip, & Lalonde, 1996; Gibbs, Naudts, Spencer, & David, 2008; Mehta et al., 2008) .
Consistent with the view that distinct dopamine receptors are able to modulate recognition memory consolidation through different mechanisms, our results show that the activation of dopamine D1 receptors, by systemic administration of a dopamine D1 receptor agonist, enhances recognition memory while the activation of dopamine D2 receptors produce no effects on this type of memory after short delays. However, since the dopamine receptor subtypes in different brain regions appear to differentially influence similar functions, carefully defining the cognitive processes to be tested against potential therapeutics is an important point. Further experiments should evaluate the effects of intra-cerebral infusions of specific dopamine agonists and antagonists into specific brain regions in order to characterize the possible differential requirement of dopamine D1 and D2 receptor types in brain areas involved in object recognition memory processing at distinct key time points.
It is noteworthy that, in the present study, pharmacological activation of D1 receptors could produce significant enhancements of novel object recognition memory even under conditions in which control rats showed considerable retention measured by exploratory preference. In contrast, previous studies examining the effects of cognitive enhancers in the novel object recognition procedure only found memory-enhancing effects in long-term memory retention tests if control animals had no significant retention. To our knowledge, this is the first study showing significant drug enhancement of novel object recognition retention in a condition in which control animals show normal memory. Together, our results indicate that dopamine receptor activation after training can produce consistent enhancing effects on long-term recognition memory, and are consistent with the view that dopamine receptors are targets for the development of cognitive enhancers.
